Crown Laboratories Acquires Aesthetics Eclipse’s Aesthetics Portfolio
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
The botulinum toxin product from Hugel expands its global reach with training and launch events.